European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE V)
|National Coordination:||Prof. Stefan Störk, Prof. Peter Heuschmann|
|Cooperation partners||Universitätsklinikum Tübingen (Prof. Tobias Geisler), Paracelsus-Krankenhaus Ruit (Professor Christian Herdeg), Universitätsklinikum Halle (Saale) (Professor Stefan Frantz), Carl-von-Basedow-Klinikum Merseburg (PD |
Dr. Roland Prondzinsky)
|Project Funding:||The local data collection is supported by the German Heart Foundation|
|Status:||Ongoing; Data collection August 2016 - April 2017|
Optimal control of cardiovascular risk factors such as diabetes, hypertension and dyslipidemia is a key component in secondary prevention in patients with coronary heart disease. Furthermore, changes in life style and behavior, such as smoking cessation, diet and physical activity have been shown to be related to a better prognosis. At regular intervals since 1995, cross-sectional surveys called EUROASPIRE (European Action on Secondary and Primary Prevention by Intervention to Reduce Events) are initiated by the European Society of Cardiology in cooperation with the European Society of Cardiovascular Prevention and Rehabilitation to assess quality of care in coronary heart disease patients across Europe. A particular focus is on the translation of guideline recommendations in clinical practice, e.g. recommendations regarding medication and achievement of treatment targets for blood pressure and LDL-cholesterol.
For the current EUROASPIRE V survey, the Institute of Clinical Epidemiology and Biometry (ICE-B, Prof. P. Heuschmann) along with the Comprehensive Heart Failure Center (CHFC, Prof S. Störk) represent the primary study center for Germany. Similar to the previous survey, coronary patients of the University Hospital Würzburg (Dept. of Medicine 1 and Dept. of Cardiac Surgery) and the Klinik Kitzinger Land (Dept. of Medicine) will be enrolled. As a novel part in EUROASPIRE V, recruitment will be expanded to two further regions to achieve a more representative view of secondary prevention in coronary heart disease patients across Germany: University Hospital of Tübingen (incl. Krankenhaus Ruit) and University Hospital Halle (incl. Klinik Saalekreis, Merseburg).
Enrollment and examination of participants will start in October 2016 and will end in March 2017. About 12 months after the study visit, telephone interviews will be performed by the ICE-B for all study participants.